IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Cash from Investing (Quarterly): 8.651M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.651M |
| December 31, 2023 | -14.69M |
| September 30, 2023 | 19.55M |
| June 30, 2023 | -6.325M |
| March 31, 2023 | 69.82M |
| December 31, 2022 | -18.81M |
| September 30, 2022 | -3.748M |
| June 30, 2022 | -183.98M |
| March 31, 2022 | -19.10M |
| December 31, 2021 | 2.24M |
| September 30, 2021 | -47.11M |
| Date | Value |
|---|---|
| June 30, 2021 | 20.72M |
| March 31, 2021 | 39.61M |
| December 31, 2020 | 21.23M |
| September 30, 2020 | 11.48M |
| June 30, 2020 | -2.953M |
| March 31, 2020 | 28.53M |
| December 31, 2019 | -143.73M |
| September 30, 2019 | -58.36M |
| June 30, 2019 | -0.433M |
| March 31, 2019 | -0.715M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-183.98M
Minimum
Jun 2022
69.82M
Maximum
Mar 2023
-13.87M
Average
-1.693M
Median
Cash from Investing (Quarterly) Benchmarks
| Akoya Biosciences Inc | -48.82M |
| Xilio Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -42.42M |
| Cash from Financing (Quarterly) | 0.152M |
| Free Cash Flow | -194.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7469 |
| Free Cash Flow to Equity (Quarterly) | -44.90M |
| Free Cash Flow to Firm (Quarterly) | -44.90M |
| Free Cash Flow Yield | -37.56% |